Alter Blanche P
NATIONAL CANCER INSTITUTE.
Blood. 2014 Jul 17;124(3):312-3. doi: 10.1182/blood-2014-04-571687.
In this issue of Blood, Gagne et al describe a cohort of 362 patients clinically classified as having Diamond-Blackfan anemia (DBA), in which 175 (48%) were found to have mutations and deletions in ribosomal protein genes or GATA1, and 8 of the remaining patients (2.2% overall) had mitochondrial gene deletions consistent with Pearson marrow-pancreas syndrome (PS). The authors propose that all patients with presumptive DBA should be tested for mitochondrial DNA (mtDNA) deletion during their initial genetic evaluation.
在本期《血液》杂志中,加涅等人描述了一组362例临床诊断为先天性纯红细胞再生障碍性贫血(DBA)的患者,其中175例(48%)被发现核糖体蛋白基因或GATA1存在突变和缺失,其余患者中有8例(总体为2.2%)存在与 Pearson 骨髓-胰腺综合征(PS)一致的线粒体基因缺失。作者建议,所有疑似DBA的患者在初次基因评估时都应检测线粒体DNA(mtDNA)缺失情况。